Peter Sonnenreich 
Key Developments from AMCP 2023 on Blockbuster Generics, Diabetes Drugs, PBM Legislation, and More
A wave of blockbuster generic drugs launches, new brand drugs that address unmet needs, ...
Biosimilars Gain Traction in Oncology but Nuances Incorporating Them Discussed at ACCC 49th Annual Meeting & Cancer Center Business Summit
As biosimilars make inroads across various disease states, oncology especially appears to have embraced ...
AAD Annual Meeting Showcases New Topical Treatments and More
New topical treatments for atopic dermatitis (AD) and for molluscum contagiosum (MC) were among ...
The Liver Meeting 2022 Asked Whether a Disease Needs a Name Change
Alarming demographic trends in mortality, promising new pharmaceutical trial data, and debate over a ...
AMCP Nexus 2022 Stirs Debate About the Future of Managed Care Practices
Debate continues to swirl around emerging managed care practices such as copay accumulators and ...
Krystal Biotech’s B-VEC Topical Gene Therapy Shows Promise in Treating Rare Skin Disease
Krystal Biotech, Inc., a clinical-stage biopharmaceutical company focused on gene therapies for dermatological diseases, ...
Ophthalmology’s Future: Eyecelerator @ AAO 2021
The ophthalmology market is healthy, having largely recovered from the impact of COVID, according ...
